FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116734756> ?p ?o ?g. }

• W2116734756 endingPage "1579" @default.
• W2116734756 startingPage "1564" @default.
• W2116734756 abstract "Sialic acids (Sias) are often conjugated to the termini of cellular glycans and are key mediators of cellular recognition. Sias are nine-carbon acidic sugars, and, in vertebrates, the major species are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), differing in structure at the C5 position. Previously, we described a positive feedback loop involving regulation of Neu5Gc expression in mouse B cells. In this context, Neu5Gc negatively regulated B-cell proliferation, and Neu5Gc expression was suppressed upon activation. Similarly, resting mouse T cells expressed principally Neu5Gc, and Neu5Ac was induced upon activation. In the present work, we used various probes to examine sialoglycan expression by activated T cells in terms of the Sia species expressed and the linkages of Sias to glycans. Upon T-cell activation, sialoglycan expression shifted from Neu5Gc to Neu5Ac, and the linkage shifted from α2,6 to α2,3. These changes altered the expression levels of sialic acid-binding immunoglobulin-like lectin (siglec) ligands. Expression of sialoadhesin and Siglec-F ligands increased, and that of CD22 ligands decreased. Neu5Gc exerted a negative effect on T-cell activation, both in terms of the proliferative response and in the context of activation marker expression. Suppression of Neu5Gc expression in mouse T and B cells prevented the development of nonspecific CD22-mediated T cell-B cell interactions. Our results suggest that an activation-dependent shift from Neu5Gc to Neu5Ac and replacement of α2,6 by α2,3 linkages may regulate immune cell interactions at several levels. Sialic acids (Sias) are often conjugated to the termini of cellular glycans and are key mediators of cellular recognition. Sias are nine-carbon acidic sugars, and, in vertebrates, the major species are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), differing in structure at the C5 position. Previously, we described a positive feedback loop involving regulation of Neu5Gc expression in mouse B cells. In this context, Neu5Gc negatively regulated B-cell proliferation, and Neu5Gc expression was suppressed upon activation. Similarly, resting mouse T cells expressed principally Neu5Gc, and Neu5Ac was induced upon activation. In the present work, we used various probes to examine sialoglycan expression by activated T cells in terms of the Sia species expressed and the linkages of Sias to glycans. Upon T-cell activation, sialoglycan expression shifted from Neu5Gc to Neu5Ac, and the linkage shifted from α2,6 to α2,3. These changes altered the expression levels of sialic acid-binding immunoglobulin-like lectin (siglec) ligands. Expression of sialoadhesin and Siglec-F ligands increased, and that of CD22 ligands decreased. Neu5Gc exerted a negative effect on T-cell activation, both in terms of the proliferative response and in the context of activation marker expression. Suppression of Neu5Gc expression in mouse T and B cells prevented the development of nonspecific CD22-mediated T cell-B cell interactions. Our results suggest that an activation-dependent shift from Neu5Gc to Neu5Ac and replacement of α2,6 by α2,3 linkages may regulate immune cell interactions at several levels." @default.
• W2116734756 created "2016-06-24" @default.
• W2116734756 creator A5017611463 @default.
• W2116734756 creator A5017969792 @default.
• W2116734756 creator A5023072109 @default.
• W2116734756 creator A5031610276 @default.
• W2116734756 creator A5034292099 @default.
• W2116734756 creator A5040414662 @default.
• W2116734756 creator A5040622310 @default.
• W2116734756 creator A5049034922 @default.
• W2116734756 creator A5049727956 @default.
• W2116734756 creator A5059002532 @default.
• W2116734756 creator A5059176441 @default.
• W2116734756 creator A5078122217 @default.
• W2116734756 date "2014-01-01" @default.
• W2116734756 modified "2023-10-11" @default.
• W2116734756 title "Functional Evaluation of Activation-dependent Alterations in the Sialoglycan Composition of T Cells" @default.
• W2116734756 cites W1498617433 @default.
• W2116734756 cites W1560865892 @default.
• W2116734756 cites W1632566425 @default.
• W2116734756 cites W1853217298 @default.
• W2116734756 cites W1900528944 @default.
• W2116734756 cites W1962224211 @default.
• W2116734756 cites W1969119554 @default.
• W2116734756 cites W1971319214 @default.
• W2116734756 cites W1971907885 @default.
• W2116734756 cites W1981407491 @default.
• W2116734756 cites W1982131071 @default.
• W2116734756 cites W1985980866 @default.
• W2116734756 cites W1992886596 @default.
• W2116734756 cites W2023692830 @default.
• W2116734756 cites W2024235284 @default.
• W2116734756 cites W2024551447 @default.
• W2116734756 cites W2029089280 @default.
• W2116734756 cites W2036493629 @default.
• W2116734756 cites W2037681486 @default.
• W2116734756 cites W2041835190 @default.
• W2116734756 cites W2046065497 @default.
• W2116734756 cites W2047345480 @default.
• W2116734756 cites W2057289747 @default.
• W2116734756 cites W2059450339 @default.
• W2116734756 cites W2068149589 @default.
• W2116734756 cites W2069047496 @default.
• W2116734756 cites W2069679620 @default.
• W2116734756 cites W2070666617 @default.
• W2116734756 cites W2071380288 @default.
• W2116734756 cites W2075028497 @default.
• W2116734756 cites W2075853683 @default.
• W2116734756 cites W2076975212 @default.
• W2116734756 cites W2087372329 @default.
• W2116734756 cites W2090145597 @default.
• W2116734756 cites W2098062600 @default.
• W2116734756 cites W2099739487 @default.
• W2116734756 cites W2112361058 @default.
• W2116734756 cites W2116372484 @default.
• W2116734756 cites W2117395989 @default.
• W2116734756 cites W2122264549 @default.
• W2116734756 cites W2128337942 @default.
• W2116734756 cites W2129148340 @default.
• W2116734756 cites W2129302556 @default.
• W2116734756 cites W2129442350 @default.
• W2116734756 cites W2133628492 @default.
• W2116734756 cites W2139974970 @default.
• W2116734756 cites W2143027850 @default.
• W2116734756 cites W2146194729 @default.
• W2116734756 cites W2150380845 @default.
• W2116734756 cites W2154872900 @default.
• W2116734756 cites W2156845267 @default.
• W2116734756 cites W2158299621 @default.
• W2116734756 cites W2161043889 @default.
• W2116734756 cites W2161622051 @default.
• W2116734756 cites W2338102355 @default.
• W2116734756 cites W2416244813 @default.
• W2116734756 cites W4240211429 @default.
• W2116734756 cites W4251633039 @default.
• W2116734756 cites W4313311439 @default.
• W2116734756 doi "https://doi.org/10.1074/jbc.m113.523753" @default.
• W2116734756 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3894337" @default.
• W2116734756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24297165" @default.
• W2116734756 hasPublicationYear "2014" @default.
• W2116734756 type Work @default.
• W2116734756 sameAs 2116734756 @default.
• W2116734756 citedByCount "27" @default.
• W2116734756 countsByYear W21167347562014 @default.
• W2116734756 countsByYear W21167347562015 @default.
• W2116734756 countsByYear W21167347562016 @default.
• W2116734756 countsByYear W21167347562017 @default.
• W2116734756 countsByYear W21167347562018 @default.
• W2116734756 countsByYear W21167347562020 @default.
• W2116734756 countsByYear W21167347562021 @default.
• W2116734756 countsByYear W21167347562022 @default.
• W2116734756 countsByYear W21167347562023 @default.
• W2116734756 crossrefType "journal-article" @default.
• W2116734756 hasAuthorship W2116734756A5017611463 @default.
• W2116734756 hasAuthorship W2116734756A5017969792 @default.
• W2116734756 hasAuthorship W2116734756A5023072109 @default.
• W2116734756 hasAuthorship W2116734756A5031610276 @default.
• W2116734756 hasAuthorship W2116734756A5034292099 @default.

• next